CIK 0001429260 · Non-accelerated filer<br>Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205157386
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-01 | Lorenz Kevin Director | Grant or award | +50,000 | 314,572 | ||
| 2023-01-01 | LOBELL J JAY Director | Grant or award | +100,000 | 1,336,000 | ||
| 2023-01-01 | Klein Dov Director | Grant or award | +100,000 | 851,015 | ||
| 2023-01-01 | Hoenlein Malcolm Director | Grant or award | +50,000 | 535,636 | ||
| 2023-01-01 | Harvey Jimmie Director | Grant or award | +100,000 | 950,000 | ||
| 2022-12-16 | Lu Lucy Director | Grant or award | +30,000 | 71,403 | ||
| 2022-12-01 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Purchase | +100,000 | $0.68 | $68K | 11,730,324 |
| 2022-11-30 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Purchase | +5,000 | $0.56 | $3K | 11,630,324 |
| 2022-11-30 | Jin David Chief Financial Officer | Purchase | +5,000 | $0.56 | $3K | 1,402,829 |
| 2022-10-26 | Jin David Chief Financial Officer | Grant or award | +1,350,000 | 1,397,829 | ||
| 2022-10-21 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Purchase | +100,000 | $0.70 | $70K | 11,625,324 |
| 2022-06-01 | ROSENWALD LINDSAY A MD President, CEO & Chairman | Grant or award | +4,264 | $0.73 | $3K | 11,734,588 |
| 2022-01-01 | Klein Dov Director | Grant or award | +100,000 | 751,015 | ||
| 2022-01-01 | WEISS MICHAEL S See Remarks | Grant or award | +1,102,986 | 12,335,136 | ||
| 2022-01-01 | Hoenlein Malcolm Director | Grant or award | +50,000 | 485,636 | ||
| 2022-01-01 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Grant or award | +1,102,986 | 11,525,324 | ||
| 2022-01-01 | Lorenz Kevin Director | Grant or award | +50,000 | 264,572 | ||
| 2022-01-01 | Harvey Jimmie Director | Grant or award | +100,000 | 850,000 | ||
| 2022-01-01 | LOBELL J JAY Director | Grant or award | +100,000 | 1,236,000 | ||
| 2022-01-01 | Rowinsky Eric K Director | Grant or award | +100,000 | 820,000 |
Page 4 of 6 · 105 trades